| Microarray-based molecular karyotyping |
|
|
| CYTOGENETICS |
|
|
| Molecular Cytogenetics |
|
|
| Preimplantation Genetic Diagnosis (PGD) |
|
|
| Ereditary Endocrinopaties |
|
|
| Pharmacogenetics |
|
|
| Biochemical Genetics |
|
|
| Reproductive Genetics |
|
|
| Forensic Genetics |
|
|
| Molecular Genetics |
 |
21 Idrossilasi - Sindrome Adreno Genitale (CYP21 gene) |
|
methylmalonic aciduria and homocystinuria, cbIC type (MMACHC) |
|
MEVALONIC ACIDURIA - HYPER-IgD SYNDROME (MVK) |
|
Achondroplasia (FGFR3 gene) |
|
Actin myopathy (ACTA1) |
|
adenosine deaminase deficiency (ADA) |
|
Adrenoleukodystrophy (ALD)-ABCD1 |
|
AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE (IGHM) |
|
Alagille syndrome (JAG1) |
|
Albinism, oculocutaneous 1 (TYR) |
|
Alpha-1-Antitrypsin deficiency (PI gene) |
|
Alzheimer - screening 7 polymorphisms |
|
Alzheimer - early onset - PSEN1 gene |
|
Alzheimer - early onset - PSEN2 gene |
|
Alzheimer disease type 1, early onset familial (APP) |
|
Amyloidosis (TTR) |
|
Sickle-Cell Anemia |
|
FANCONI anemia goup C |
|
Molecular Aneuploidy Screening (QF-PCR) on chromosomes 13-18-21-X-Y |
|
Molecular Aneuploidy Screening (QF-PCR) on chromosomes 21-X-Y |
|
ANIRIDIA (PAX6) |
|
Apolipoprotein E (ApoE): E2, E3, E4 alleles Genotyping |
|
AROMATASE - deficiency (p450) |
|
Friedreich Ataxia (FRDA) |
|
Spinocerebellar Ataxia (SCA) type 1 (ATXN1) |
|
Spinocerebellar Ataxia (SCA) type 2 (ATXN2) |
|
Spinocerebellar Ataxia (SCA) type 3 (ATXN3) |
|
Spinocerebellar Ataxia (SCA) type 6 (CACNA1A) |
|
Spinocerebellar Ataxia (SCA) type 7 (ATXN7) |
|
Spinal-Bulbar Muscular Atrophy (SBMA) - Kennedy disease (AR) |
|
SPINAL MUSCULAR ATROPHY TYPE I,II,III (SMA) |
|
Autism |
|
Bartter syndrome type 1 (KCNJ1) |
|
Beckwith-Wiedemann syndrome (CDKN1C) |
|
blepharophimosis - ptosis - epicanthus inversus syndrome (BEPS): FOXL2 gene |
|
BLOOM SYNDROME (BLM) |
|
Bruton tyrosine kinase (BTK gene) - Bruton disease |
|
CANAVAN disease (ASPA) |
|
Ceroid-lipofuscinosis, neuronal, type 6 (CLN6) |
|
CEROID LIPOFUSCINOSIS NEURONAL 1 (PPT1) |
|
CHARCOT-MARIE-TOOTH type 1A (PMP22) - linkage |
|
Charcot-Marie-Tooth X-Linked |
|
Congenital disorder of glycosylation, type 1A (PMM2) |
|
Crigler-Najjar syndrome (UGT1A1) |
|
Diamond Blackfan Anemia (RPS19 gene) |
|
DYSAUTONOMIA, FAMILIAL (FD) |
|
Uniparental Disomy |
|
diastrophic dysplasia (SLC26A2) |
|
Primary Dystonia - DYT1 gene |
|
Limb-Girdle Muscular Dystrophy - 1C (LGMD - 1C) - CAV3 gene |
|
Limb-Girdle Muscular Dystrophy - 2C (LGMD - 2C) - SGCG gene |
|
facioscapulohumeral muscular dystrophy (FSHD) |
|
Myotonic Dystrophy (Steinert Disease) - (DMPK) |
|
DYSTROPHIA MYOTONICA 2 (DM2) - (ZNF9) |
|
Becker Muscular Dystrophy (DMB) |
|
Duchenne Muscular Dystrophy (DMD) |
|
Duchenne - Becker Muscular Dystrophy (DMD/DMB) - Linkage analysis |
|
Duane-radial ray syndrome (SALL4) |
|
Ectodermal dysplasia 1 (EDA) |
|
ECTRODACTYLY ECTODERMAL DYSPLASIA (TP63) |
|
Hemochromatosis type 4 (Ferroportin gene ) 2 mutations |
|
Hemochromatosis classic (HFE gene ) 12 mutations screening |
|
Hemochromatosis classic (HFE gene) 3 mutations screening |
|
Hemochromatosis 18 mutations screening |
|
Hemochromatosis type 3 (TFR2 gene ) 4 mutations screening |
|
Hemophilia A (FVIII gene) |
|
Hemophilia B (FIX gene) |
|
EPIDERMOLYSIS BULLOSA Simplex - Dowling-Meara - KRT5 and KRT14 genes |
|
EPIDERMOLYSIS BULLOSA Simplex - Mottled-Hyperpigmentation - KRT5 gene |
|
EPIDERMOLYSIS BULLOSA Simplex - Weber-Cockayne - KRT5 gene |
|
Exostoses (multiple) 1 (EXT1) |
|
exostoses, multiple type 1(EXT1) |
|
exostoses, multiple type 2 (EXT2) |
|
Faciogenital dysplasia (FGD1) |
|
FACTOR VII DEFICIENCY (F7) |
|
Familial Mediterranean Fever (FMF) - Screening most frequent mutations MEFV gene |
|
Familial Mediterranean Fever (FMF) - Total MEFV gene screening |
|
PHENYLKETONURIA (PAH gene) |
|
Cistic Fibrosis - 200 mutations screening (CFTR) |
|
Cistic Fibrosis - 33 mutations + 5Tpolymorphism screening (CFTR) |
|
Cistic Fibrosis - 100 mutations screening (CFTR) |
|
Cistic Fibrosis - total CFTR gene screening |
|
GALACTOSIDASE-BETA -1 DEFICIENCY (GLB1) |
|
galactosemia, type I (GALT) |
|
Gangliosidosis (GLB1) |
|
Gaucher disease - (GBA most frequent mutations screening ) |
|
GAUCHER disease - (GBA) - complete gene screening |
|
GILBERT SYNDROME (UGT1A1) |
|
GLUTARICACIDEMIA I (GCDH gene) |
|
Glycogen storage disease type 1a (GSD1a) |
|
Glycogen storage disease type I, von Gierke disease (G6PC) |
|
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED (CYBB) |
|
GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G6PD gene) |
|
HOLT-ORAM (TBX5 gene) |
|
Huntington Disease (HD) |
|
Ichthyosis, lamellar (TGM1) |
|
Immunodysregulation, polyendocrinopathy, enteropathy (FOXP3) |
|
ANDROGEN INSENSITIVITY SYNDROME (AR) |
|
interleukin 3 receptor, alpha (IL3RA) |
|
HYPER-IgD SYNDROME (MVK) |
|
Hypocondroplasia (FGFR3 gene) |
|
Hypophosphatasia type 1 (ALPL) |
|
HYPOMAGNESEMIA, PRIMARY (CLDN16) |
|
ADRENAL HYPOPLASIA, CONGENITAL - AHC (DAX1) |
|
Keratitis (PAX6) |
|
KRABBE Disease (GALC gene) |
|
Leri-Weill dyschondrosteosis (SHOX) |
|
Lesch-Nyhan Syndrome (HPRT1 gene) |
|
Metachromatic leukodystrophy (ARSA) |
|
hemophagocytic lymphohistiocytosis (PFR1) |
|
lymphoproliferative syndrome X-linked - (SH2D1A) |
|
LOWE OCULOCEREBRORENAL SYNDROME (OCRL1) |
|
HOXA13 |
|
Maple syrup urine disease (MSUD) |
|
Medium Chain Acyl-CoA dehydrogenase (MCAD) deficit |
|
Melas Syndrome |
|
Mucolipidosis type IV (MLIV) |
|
MUCOPOLYSACCHARIDOSIS TYPE IIIA - SANFILIPPO SYNDROME (SGSH gene) |
|
MUCOPOLYSACCHARIDOSIS TYPE IIIB (NAGLU) |
|
MUCOPOLYSACCHARIDOSIS TYPE IVB (GLB1) |
|
Mucopolysaccharidosis VI (Arylsulphatase B - ARSB) |
|
mucopolysaccharidosis, type I (IDUA) |
|
NEPHROTIC SYNDROME - STEROID RESISTANT (NPHS2) |
|
Nemaline myopathy (CFL2) |
|
Neutropenia severe congenital type 1 (ELA2) |
|
Niemann-Pick disease type A (SMPD1) |
|
Niemann-Pick disease type B (SMPD1) |
|
Omenn syndrome (RAG1) |
|
Pancreatitis - hereditary (PRSS1-TYR) |
|
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION (PANK2) |
|
SPASTIC PARAPLEGIA ( SPG3A) |
|
Peutz-Jeghers syndrome (STK11) |
|
Propionic acidemia B (PCCB) |
|
Pycnodysostosis (CTSK) |
|
polycystic kidney disease (PKD1) - linkage |
|
POLYCYSTIC KIDNEY DISEASE - AUTOSOMAL RECESSIVE (PKHD1) - linkage analysis |
|
RETINITIS PIGMENTOSA (RHODOPSIN - RHO gene) |
|
RETT Syndrome - MECP2 gene |
|
AMYOTROPHIC LATERAL SCLEROSIS 1 (SOD1) |
|
TUBEROUS SCLEROSIS ( TSC1) |
|
Shwachman-Bodian-Diamond syndrome (SBDS) |
|
HOXD13 |
|
Smith-Lemli-Opitz syndrome (DHCR7) |
|
Hereditary DEAFNESS - (CX26 total gene screening) |
|
Hereditary DEAFNESS - (CX30 total gene screening) |
|
Hereditary DEAFNESS - (CX26-most frequent mutations screening) |
|
SRY - Sex Determining region Y |
|
Superoxide dismutase 1 (SOD1) |
|
Thalassemia Beta - Total beta globin gene |
|
Thalassemia Beta - Screening of 23 most frequent mutations of beta globin gene |
|
TAY SACHS (HEXA) |
|
Tyrosinemia type I (FAH) |
|
Van der Woude syndrome (IRF6) |
|
Wiskott-Aldrich Syndrome (WAS gene) |
|
Fragile X (FRAXA gene) |
|
Fragile X (FRAXE gene) |
|
| Preventive Genetic Testing |
|
|
| HLA - Typing |
|
|
| Paternity and Parentage Testing |
|
|
| Male Infertility |
|
|
| Female infertility |
|
ANTIPHOSPHOLIPID ANTIBODIES (ACA, APA, LAC) |
|
Karyotype |
|
FSHR |
|
GALT gene - Premature Overian Failure |
|
INHIBIN A gene (Premature Ovarian failure) |
|
INHIBIN B |
|
LH- Receptor (LHR) gene |
|
LH- Receptor (LHR) gene |
|
Luteinizing hormone Beta (LHB) |
|
AUTOIMMUNITY (ANA, ENA, ASMA, LAC, ACA, AOA, ATGA, APA) |
|
Thrombophilia Panel 13 mutations - Fact. V Leiden, Fact. V Y1702C, Fact.II, MTHFR (C677T, A1298C), Beta Fibrinogen, PAI-1, Factor XIII, HPA, ACE, ApoE, ApoB, AGT ) |
|
Fragile X (FRAXA gene) |
|
Fragile X (FRAXE gene) |
|
| Infectious diseases - molecular testing |
|
|
| Nutrigenetics |
|
|
| Molecular Oncology (Early Diagnosis) |
|
|
| Molecular Oncology (Predictive Tests) |
|
|
| Osteoporosis |
|
|
| Cardiovascular Diseases (Ereditary Thrombophilia) |
|
|
| Recurrent Miscarriage |
|
|
|
